Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. / Lautenbach, A.; Wernecke, M.; Riedel, N.; Veigel, J.; Yamamura, J.; Keller, S.; Jung, R.; Busch, P.; Mann, O.; Knop, F. K.; Holst, J. J.; Meier, J. J.; Aberle, J.

In: Diabetes - Metabolism: Research and Reviews (Print Edition), Vol. 34, No. 7, e3025, 10.2018, p. 1-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lautenbach, A, Wernecke, M, Riedel, N, Veigel, J, Yamamura, J, Keller, S, Jung, R, Busch, P, Mann, O, Knop, FK, Holst, JJ, Meier, JJ & Aberle, J 2018, 'Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss', Diabetes - Metabolism: Research and Reviews (Print Edition), vol. 34, no. 7, e3025, pp. 1-8. https://doi.org/10.1002/dmrr.3025

APA

Lautenbach, A., Wernecke, M., Riedel, N., Veigel, J., Yamamura, J., Keller, S., Jung, R., Busch, P., Mann, O., Knop, F. K., Holst, J. J., Meier, J. J., & Aberle, J. (2018). Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. Diabetes - Metabolism: Research and Reviews (Print Edition), 34(7), 1-8. [e3025]. https://doi.org/10.1002/dmrr.3025

Vancouver

Lautenbach A, Wernecke M, Riedel N, Veigel J, Yamamura J, Keller S et al. Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. Diabetes - Metabolism: Research and Reviews (Print Edition). 2018 Oct;34(7):1-8. e3025. https://doi.org/10.1002/dmrr.3025

Author

Lautenbach, A. ; Wernecke, M. ; Riedel, N. ; Veigel, J. ; Yamamura, J. ; Keller, S. ; Jung, R. ; Busch, P. ; Mann, O. ; Knop, F. K. ; Holst, J. J. ; Meier, J. J. ; Aberle, J. / Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. In: Diabetes - Metabolism: Research and Reviews (Print Edition). 2018 ; Vol. 34, No. 7. pp. 1-8.

Bibtex

@article{115e2b306ffb476ca9c3e01b61139c51,
title = "Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss",
abstract = "Background:Obesity has been shown to trigger adaptive increases in pancreasparenchymal and fat volume. Consecutively, pancreatic steatosis may lead to beta‐cell dysfunction. However, it is not known whether the pancreatic tissue compo-nents decrease with weight loss and pancreatic steatosis is reversible followingRoux‐en‐Y gastric bypass (RYGB). Therefore, the objective of the study was toinvestigate the effects of RYGB‐induced weight loss on pancreatic volume andglucose homeostasis.Methods:Eleven patients were recruited in the Obesity Centre of the UniversityMedical Centre Hamburg‐Eppendorf. Before and 6 months after RYGB, total GLP‐1levels were measured during oral glucose tolerance test. To assess changes invisceral adipose tissue and pancreatic volume, MRI was performed. Measures ofglucose homeostasis and insulin indices were assessed. Fractional beta‐cell areawas estimated by correlation with the C‐peptide‐to‐glucose ratio; beta‐cell masswas calculated by the product of beta‐cell area and pancreas parenchymal weight.Results:Pancreas volume decreased from 83.8 (75.7‐92.0) to 70.5 (58.8‐82.3) cm3(mean [95% CI],P= .001). The decrease in total volume was associated with asignificant decrease in fat volume. Fasting insulin and C‐peptide were lower postRYGB. HOMA‐IR levels decreased, whereas insulin sensitivity increased (P= .03). Thiswas consistent with a reduction in the estimated beta‐cell area and mass.Conclusions:Following RYGB, pancreatic volume and steatosis adaptivelydecreased to“normal”levels with accompanying improvement in glucose homeosta-sis. Moreover, obesity‐driven beta‐cell expansion seems to be reversible; however,future studies must define a method to more accurately estimate functional beta‐cellmass to increase our understanding of glucose homeostasis after RYGB.",
keywords = "beta-cell, GLP-1, insulin, pancreas, RYGB",
author = "A. Lautenbach and M. Wernecke and N. Riedel and J. Veigel and J. Yamamura and S. Keller and R. Jung and P. Busch and O. Mann and Knop, {F. K.} and Holst, {J. J.} and Meier, {J. J.} and J. Aberle",
year = "2018",
month = oct,
doi = "10.1002/dmrr.3025",
language = "English",
volume = "34",
pages = "1--8",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "Wiley",
number = "7",

}

RIS

TY - JOUR

T1 - Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss

AU - Lautenbach, A.

AU - Wernecke, M.

AU - Riedel, N.

AU - Veigel, J.

AU - Yamamura, J.

AU - Keller, S.

AU - Jung, R.

AU - Busch, P.

AU - Mann, O.

AU - Knop, F. K.

AU - Holst, J. J.

AU - Meier, J. J.

AU - Aberle, J.

PY - 2018/10

Y1 - 2018/10

N2 - Background:Obesity has been shown to trigger adaptive increases in pancreasparenchymal and fat volume. Consecutively, pancreatic steatosis may lead to beta‐cell dysfunction. However, it is not known whether the pancreatic tissue compo-nents decrease with weight loss and pancreatic steatosis is reversible followingRoux‐en‐Y gastric bypass (RYGB). Therefore, the objective of the study was toinvestigate the effects of RYGB‐induced weight loss on pancreatic volume andglucose homeostasis.Methods:Eleven patients were recruited in the Obesity Centre of the UniversityMedical Centre Hamburg‐Eppendorf. Before and 6 months after RYGB, total GLP‐1levels were measured during oral glucose tolerance test. To assess changes invisceral adipose tissue and pancreatic volume, MRI was performed. Measures ofglucose homeostasis and insulin indices were assessed. Fractional beta‐cell areawas estimated by correlation with the C‐peptide‐to‐glucose ratio; beta‐cell masswas calculated by the product of beta‐cell area and pancreas parenchymal weight.Results:Pancreas volume decreased from 83.8 (75.7‐92.0) to 70.5 (58.8‐82.3) cm3(mean [95% CI],P= .001). The decrease in total volume was associated with asignificant decrease in fat volume. Fasting insulin and C‐peptide were lower postRYGB. HOMA‐IR levels decreased, whereas insulin sensitivity increased (P= .03). Thiswas consistent with a reduction in the estimated beta‐cell area and mass.Conclusions:Following RYGB, pancreatic volume and steatosis adaptivelydecreased to“normal”levels with accompanying improvement in glucose homeosta-sis. Moreover, obesity‐driven beta‐cell expansion seems to be reversible; however,future studies must define a method to more accurately estimate functional beta‐cellmass to increase our understanding of glucose homeostasis after RYGB.

AB - Background:Obesity has been shown to trigger adaptive increases in pancreasparenchymal and fat volume. Consecutively, pancreatic steatosis may lead to beta‐cell dysfunction. However, it is not known whether the pancreatic tissue compo-nents decrease with weight loss and pancreatic steatosis is reversible followingRoux‐en‐Y gastric bypass (RYGB). Therefore, the objective of the study was toinvestigate the effects of RYGB‐induced weight loss on pancreatic volume andglucose homeostasis.Methods:Eleven patients were recruited in the Obesity Centre of the UniversityMedical Centre Hamburg‐Eppendorf. Before and 6 months after RYGB, total GLP‐1levels were measured during oral glucose tolerance test. To assess changes invisceral adipose tissue and pancreatic volume, MRI was performed. Measures ofglucose homeostasis and insulin indices were assessed. Fractional beta‐cell areawas estimated by correlation with the C‐peptide‐to‐glucose ratio; beta‐cell masswas calculated by the product of beta‐cell area and pancreas parenchymal weight.Results:Pancreas volume decreased from 83.8 (75.7‐92.0) to 70.5 (58.8‐82.3) cm3(mean [95% CI],P= .001). The decrease in total volume was associated with asignificant decrease in fat volume. Fasting insulin and C‐peptide were lower postRYGB. HOMA‐IR levels decreased, whereas insulin sensitivity increased (P= .03). Thiswas consistent with a reduction in the estimated beta‐cell area and mass.Conclusions:Following RYGB, pancreatic volume and steatosis adaptivelydecreased to“normal”levels with accompanying improvement in glucose homeosta-sis. Moreover, obesity‐driven beta‐cell expansion seems to be reversible; however,future studies must define a method to more accurately estimate functional beta‐cellmass to increase our understanding of glucose homeostasis after RYGB.

KW - beta-cell

KW - GLP-1

KW - insulin

KW - pancreas

KW - RYGB

U2 - 10.1002/dmrr.3025

DO - 10.1002/dmrr.3025

M3 - Journal article

C2 - 29768729

VL - 34

SP - 1

EP - 8

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 7

M1 - e3025

ER -

ID: 209385897